Psychiatric Morbidity in HIV Patients

1998 ◽  
Vol 43 (1) ◽  
pp. 51-56 ◽  
Author(s):  
Hani Raoul Khouzam ◽  
Nancy J Donnelly ◽  
Nabil F Ibrahim
Keyword(s):  
Quality Of Life ◽  
Psychiatric Illness ◽  
Literature Search ◽  
Psychiatric Morbidity ◽  
Clinical Information ◽  
Hiv And Aids ◽  
Psychiatric Evaluation ◽  
Diagnostic Code ◽  
Dsm Iv

Objective: To provide an accessible source of clinical information related to the diagnosis and treatment of psychiatric morbidity associated with HIV infection. Method: A selective MEDLINE literature search was used to identify 225 relevant articles, 67 of which were selected for inclusion based upon the presence of psychiatric morbidity. Psychiatric morbidity was defined by the presence of a DSM-IV diagnostic code reflecting psychiatric illness. Results: HIV-infected patients have high rates of psychiatric morbidity. Conclusion: The psychiatric evaluation and treatment of psychiatric morbidity improve the quality of life of HIV and AIDS patients.

scholarly journals Gender Differences in Remission and Recovery of Schizophrenic and Schizoaffective Patients: Preliminary Results of a Prospective Cohort Study

2012 ◽  
Vol 2012 ◽  
pp. 1-8 ◽  
Author(s):  
Bernardo Carpiniello ◽  
Federica Pinna ◽  
Massimo Tusconi ◽  
Enrico Zaccheddu ◽  
Francesca Fatteri
Keyword(s):  
Quality Of Life ◽  
Clinical Remission ◽  
Mental Health Center ◽  
Well Being ◽  
Clinical Severity ◽  
Psychiatric Evaluation ◽  
Subjective Well Being ◽  
Axis I ◽  
Dsm Iv

The aim of the paper was to evaluate rates of clinical remission and recovery according to gender in a cohort of chronic outpatients attending a university community mental health center who had been diagnosed with schizophrenia and schizoaffective disorder according to DSM-IV-TR. A sample of 100 consecutive outpatients (70 males and 30 females) underwent comprehensive psychiatric evaluation using the Structured Clinical Interview for Diagnosis of Axis I and II DSM-IV (SCID-I and SCID-II, Version R) and an assessment of psychopathology, social functioning, clinical severity, subjective wellbeing, and quality of life, respectively by means of PANSS (Positive and Negative Syndrome Scale), PSP (Personal and Social Performance), CGI-SCH (Clinical Global Impression—Schizophrenia scale), SWN-S (Subjective Well-being under Neuroleptics—scale), and WHOQOL (WHO Quality of Life). Rates of clinical remission and recovery according to different criteria were calculated by gender. Higher rates of clinical remission and recovery were generally observed in females than males, a result consistent with literature data. Overall findings from the paper support the hypothesis of a better outcome of the disorders in women, even in the very long term.

Psychiatric morbidity, Stress and Quality of Life Among Geriatric Dermatology Patients: Therapeutic Considerations from an Indian Perspective

2021 ◽  
Author(s):  
Archana Anandakumar Geetha ◽  
Ettappurath N. Abdul Latheef ◽  
Sreekanth Sukumarakurup ◽  
Keerankulangara Devi ◽  
Mohammad Jafferany
Keyword(s):  
Quality Of Life ◽  
Psychiatric Morbidity ◽  
Geriatric Dermatology ◽  
Therapeutic Considerations ◽  
Indian Perspective

scholarly journals Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse

2020 ◽  
Vol 21 (8) ◽  
pp. 2940
Author(s):  
Antonelly Cassio Alves de Carvalho ◽  
Gabriela Achete de Souza ◽  
Samylla Vaz de Marqui ◽  
Élen Landgraf Guiguer ◽  
Adriano Cressoni Araújo ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Inflammatory Bowel Diseases ◽  
Literature Search ◽  
Cannabis Sativa ◽  
Antioxidant Properties ◽  
Number Of Patients ◽  
Bowel Diseases ◽  
Inflammatory Bowel ◽  
Anti Inflammatory

Inflammatory bowel diseases (IBD) are characterized by a chronic and recurrent gastrointestinal condition, including mainly ulcerative colitis (UC) and Crohn’s disease (CD). Cannabis sativa (CS) is widely used for medicinal, recreational, and religious purposes. The most studied compound of CS is tetrahydrocannabinol (THC) and cannabidiol (CBD). Besides many relevant therapeutic roles such as anti-inflammatory and antioxidant properties, there is still much controversy about the consumption of this plant since the misuse can lead to serious health problems. Because of these reasons, the aim of this review is to investigate the effects of CS on the treatment of UC and CD. The literature search was performed in PubMed/Medline, PMC, EMBASE, and Cochrane databases. The use of CS leads to the improvement of UC and CD scores and quality of life. The medical use of CS is on the rise. Although the literature shows relevant antioxidant and anti-inflammatory effects that could improve UC and CD scores, it is still not possible to establish a treatment criterion since the studies have no standardization regarding the variety and part of the plant that is used, route of administration and doses. Therefore, we suggest caution in the use of CS in the therapeutic approach of IBD until clinical trials with standardization and a relevant number of patients are performed.

Psychiatric and Social Outcome of Liver Transplantation

1995 ◽  
Vol 166 (4) ◽  
pp. 521-524 ◽  
Author(s):  
Ian Collis ◽  
Andrew Burroughs ◽  
Keith Rolles ◽  
Geoffrey Lloyd
Keyword(s):  
Quality Of Life ◽  
Liver Transplantation ◽  
Nottingham Health Profile ◽  
General Health Questionnaire ◽  
Psychiatric Morbidity ◽  
Medical Patients ◽  
Post Transplantation ◽  
Tertiary Referral Centre ◽  
Cross Sectional

BackgroundThis study measures psychiatric morbidity, quality of life, and cognitive function after liver transplantation.MethodWe undertook a cross-sectional study, with a longitudinal subgroup. The setting was a tertiary referral centre for liver transplantation. The subjects were 30 post-liver-transplantation patients, including 11 also interviewed before the operation. The main outcome measures were the Clinical Interview Schedule (CIS), the General Health Questionnaire (GHQ), the Nottingham Health Profile (NHP), and the Mini-Mental State Examination (MMSE).ResultsOf the patients, 8/30 were CIS cases, and 7/30 were GHQ cases. NHP scores were higher than a previous postal study indicated, with less impairment after than before transplant. MMSE scores were 24–30. Median GHQ was 7.0 before operation and 1.0 after operation (P = 0.03), with no significant change in CIS score.ConclusionLiver transplantation improves quality of life, but not to the level of the general population; post-transplantation patients have a prevalence of psychiatric morbidity comparable with that of general medical patients.

scholarly journals Clinical Holistic Medicine: A Pilot Study on HIV and Quality of Life and a Suggested Cure for HIV and AIDS

2004 ◽  
Vol 4 ◽  
pp. 264-272 ◽  
Author(s):  
Søren Ventegodt ◽  
Trine Flensborg-Madsen ◽  
Niels Jørgen Andersen ◽  
Mohammed Morad ◽  
Joav Merrick
Keyword(s):  
Quality Of Life ◽  
Hiv And Aids ◽  
Cd4 Count ◽  
Holistic Medicine ◽  
Cross Sectional ◽  
Ethical Attitude ◽  
Validated Questionnaire ◽  
Clinically Significant ◽  
Higher Consciousness

This study was undertaken to examine the association between the immunological impact of HIV (measured by CD4 count) and global self-assessed quality of life (QOL) (measured with QOL1) for people suffering from HIV, to see if the connection was large and statistically strong enough to support our hypothesis of a strong QOL-immunological connection through the nonspecific, nonreceptor-mediated immune system, and thus to give a rationale for a holistic cure for HIV. This cross-sectional population study in Uganda included 20 HIV infected persons with no symptoms of AIDS and a CD4 count above 200 mill./liter. The main outcome measures were CD4 count, global QOL measured with the validated questionnaire QOL1, translated to Luganda and translated back to English. We found a large, clinically significant correlation between the number of T-helper cells (CD4) and global self-assessed quality of life (QOL1) (r = 0.57, p = 0.021), when controlled for age, gender, and years of infection. Together with other studies and holistic medicine theory, the results have given rationale for a holistic cure for HIV. We suggest, based on our findings and theoretical considerations, that HIV patients who improve their global QOL, also will improve their CD4 counts. Using the technique of holistic medicine based on the life mission theory and the holistic process theory of healing, we hypothesize that the improvement of QOL can have sufficient biological effect on the CD4, which could avoid or postpone the development of AIDS. A holistic HIV/AIDS cure improving the QOL draws on hidden resources in the person and is thus affordable for everybody. Improving global QOL also means a higher consciousness and a more ethical attitude, making it more difficult for the HIV-infected person to pass on the infection.

scholarly journals Assessment of psychiatric morbidity and quality of life in children and adolescents with cutaneous leishmaniasis and their parents

2015 ◽  
Vol 5 ◽  
pp. 344-348 ◽  
Author(s):  
Enver Turan ◽  
Hasan Kandemir ◽  
Yavuz Yeşilova ◽  
Suat Ekinci ◽  
Osman Tanrıkulu ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Children And Adolescents ◽  
Cutaneous Leishmaniasis ◽  
Psychiatric Morbidity

scholarly journals Vision-related Quality of Life in Patients With Glaucoma: the Role of Illness Perceptions

2021 ◽  
Author(s):  
Qiqi Zhang ◽  
Wenzhe Zhou ◽  
Di Song ◽  
Yanqian Xie ◽  
Hao Lin ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Illness Perceptions ◽  
Linear Regression Analysis ◽  
Illness Perception ◽  
Clinical Information ◽  
Cross Sectional Study ◽  
Cross Sectional ◽  
Illness Perception Questionnaire ◽  
Related Quality

Abstract Purpose: To explore the predictive effect of illness perceptions on vision-related quality of life (VRQoL) in Chinese glaucoma patients.Methods: In this cross-sectional study, 97 patients with glaucoma completed the Brief Illness Perception Questionnaire (BIPQ), the Glaucoma Quality of Life-15 (GQL-15), and a questionnaire with sociodemographic and clinical information. Correlation analysis and hierarchical linear regression analysis were performed.Results: The BIPQ total score was positively correlated with the scores of the total GQL-15 and its four dimensions. Chronic comorbidities, type of glaucoma, best-corrected visual acuity (BCVA), mean defect (MD) of visual field in the better eye, and identity in the BIPQ were the critical predictors of VRQoL. Illness perceptions independently accounted for 7.8% of the variance in the VRQoL of glaucoma patients.Conclusions: Patients with stronger illness perceptions who perceive themselves as having more glaucoma symptoms are likely to experience worse VRQoL. Illness perceptions in glaucoma patients deserve clinical attention, and further studies are needed to examine whether cognitive interventions targeting illness perceptions can improve VRQoL.

scholarly journals Quality of life in a residential setting

1989 ◽  
Vol 13 (9) ◽  
pp. 492-494 ◽  
Author(s):  
Ian Leonard
Keyword(s):  
Quality Of Life ◽  
Seizure Frequency ◽  
Psychiatric Illness ◽  
David Lewis ◽  
Residential Setting ◽  
Mental Handicap ◽  
Clinical Measures

The David Lewis Centre for Epilepsy has approximately 300 adult residents. All have epilepsy, which is often only partly alleviated by available treatments; many have mental handicap or psychiatric illness, adding to their total disability. The Centre's explicit aim of understanding and caring for people with epilepsy implies concern not just for clinical measures such as seizure frequency, but for our residents' quality of life.

scholarly journals THE RELATIONSHIP OF BASIC CLINICAL STATUS WITH THE QUALITY OF LIFE OF HIV AND AIDS PATIENTS

2020 ◽  
Vol 8 (3) ◽  
pp. 246
Author(s):  
Lilis Masyfufah ◽  
Erwin Astha Triyono
Keyword(s):  
Quality Of Life ◽  
Smoking Status ◽  
Clinical Status ◽  
Immune Deficiency Syndrome ◽  
Hiv And Aids ◽  
Cd4 Count ◽  
Cross Sectional ◽  
Relationship Of ◽  
The Relationship

Background: The success of individual antiretroviral drug (ARV) treatment in patients with human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS) was determined by conducting a routine evaluation of the patients’ Cluster of Differentiation 4 (CD4) count. The indicators used to measure the success of the HIV and AIDS treatment were mortality, mobility, and quality of life (QoL). Purpose: The purpose of this research was to analyze the relationship between clinical status (smoking status, duration of ARV therapy, the CD4 count, and body mass index [BMI]) and the QoL of patients with HIV and AIDS who were stable during treatment. Methods: This type of research was quantitative analytical research with a cross-sectional design. This research was conducted at Dr. Soetomo Hospital, Surabaya, from September to November 2017. The study population was patients with HIV and AIDS in Dr. Soetomo Hospital, Surabaya. The research sample was taken by purposive sampling with the inclusion criteria being patients with HIV and AIDS who had been treated for ≥6 months with adherence ≥95% and who came directly to the hospital. Results: The majority of respondents were female (53.36%), junior/senior high school graduates (66.67%), married (62.22%), non-smoking (75.56%), had undergone ARV therapy for ±10 years (77.78%), and had a QoL in the adequate category (62.22%). The basic clinical status with a significant relationship with the respondents’ QoL were the CD4 count (p = 0.00) and BMI (p = 0.00). Conclusion: There was a relationship of the CD4 count and BMI with the QoL of the patients with HIV and AIDS.

scholarly journals Atypical depression in growth hormone deficient adults, and the beneficial effects of growth hormone treatment on depression and quality of life

2004 ◽  
pp. 325-332 ◽  
Author(s):  
T Mahajan ◽  
A Crown ◽  
S Checkley ◽  
A Farmer ◽  
S Lightman
Keyword(s):  
Quality Of Life ◽  
Growth Hormone ◽  
Rating Scales ◽  
Nottingham Health Profile ◽  
Psychiatric Evaluation ◽  
Gh Therapy ◽  
Gh Treatment ◽  
Psychiatric Interview ◽  
Atypical Depression

OBJECTIVE: Some growth hormone deficient adults (GHDAs) have an impaired quality of life, which may improve with growth hormone (GH) treatment. The objective of our study was to make an in-depth psychiatric evaluation of patients with adult-onset (AO) and childhood-onset (CO) GH deficiency (GHD), and to assess the time course of changes in their quality of life and symptoms of depression in response to GH treatment. DESIGN: The study design was a 4-month, double-blind, cross-over, placebo-controlled trial of GH therapy. METHODS:We used a detailed psychiatric interview to characterise 25 patients with proven GHD at baseline. They were reassessed at monthly intervals during treatment with GH or placebo, using the Nottingham Health Profile and two well-recognised depression rating scales. RESULTS: 11/18 (61%) of the patients with AO-GHD, but 0/7 of the patients with CO-GHD, were found to have atypical depression at baseline. There were significant improvements in the depression rating scale scores after 2 months of GH therapy, with significant improvements in emotional reaction and social isolation scores from 1 month, and in energy levels and sleep disturbance from 2 and 3 months respectively. CONCLUSIONS: The results of our study confirm that a large proportion of GHDAs have unequivocal psychiatric morbidity, and suggest that a response to treatment can be seen after a short trial of GH therapy. We hypothesise that this rapid improvement of symptoms of atypical depression represents a direct central effect of GH therapy.

Sign in / Sign up

Export Citation Format

Share Document